Catalyst Wire Dossier Catalyst Wire Dossier

Crinecerfont

crinecerfont · Neurocrine Biosciences
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Crinecerfont, covering 2025-02-05 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old [Phase 2]

See pricing